Canada markets closed

Nykode Therapeutics AS (5VB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.1460-0.0360 (-3.05%)
At close: 08:20AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
12,902
12,902
7,168
33,963
215,000
Operating Expenses
Research Development
29,358
29,358
26,774
16,300
10,627
Selling General and Administrative
6,278
6,278
8,892
9,283
8,559
Total Operating Expenses
70,984
70,984
60,324
44,738
36,738
Operating Income or Loss
-58,082
-58,082
-53,156
-10,775
178,262
Interest Expense
224
224
241
130
46
Income Before Tax
-44,086
-44,086
-50,983
-11,118
180,905
Income Tax Expense
-8,932
-8,932
-8,240
-1,704
31,130
Income from Continuing Operations
-35,154
-35,154
-42,743
-9,414
149,774
Net Income
-35,154
-35,154
-42,743
-9,414
149,774
Net Income available to common shareholders
-35,154
-35,154
-42,743
-9,414
149,774
Basic EPS
-0.14
-
-0.15
-0.03
0.54
Diluted EPS
-0.14
-
-0.15
-0.03
0.51
Basic Average Shares
305,532
-
290,119
286,345
279,643
Diluted Average Shares
305,532
-
290,119
286,345
296,145